Access to healthcare

Pricing our medicines to help ensure patient access

Access to healthcare

Helping patients in need

Insurance coverage can be challenging, financial circumstances can change quickly, and sometimes patients need assistance paying for their prescription medications or vaccines.

How we do business

Changing the way we do business

When was the last time you upended your life – reevaluated the way you work, radically shifted how you measure success – and convinced 100,000 people to do it with you?

How we do business

Fast-tracking our response to pandemics

In the wake of global pandemics such as Ebola and Zika, there is consensus that the world needs to be better prepared.

How we do business

Putting it plainly

In our opinion, being transparent is not a path to failure — it is a source of strength.

How we do business

Hunting for energy savings

How we do business

Creating bricks and benches out of medical waste

How we do business

Evolving our graduated approach to intellectual property

In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.

Our people

Building future leaders

Everyone talks about “leadership.” Business schools teach courses on it and war metaphors abound. Great leaders are often described as near-mythical creatures - like unicorns.

Our people

Designing inspiring and healthy workplaces

As a healthcare company, we focus on how we can best support the wellbeing of patients, consumers, and our employees.

Innovation

On target for a new era of drug discovery?

Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.

Patients & consumers

GSK IMPACT Awards: 20 years of healthy communities

How we do business

Buyer beware: importing drugs comes with big risks

How we do business

How doctors and insurers get information about medicines for patients

How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?

Our people

The gift of time: increased parental leave

We all want the time and energy to invest in the things that matter most. That is why GSK is expanding our paid parental leave benefit in 2017.

Our people

Work Together, Give Together

One way GSK supports communities is the through the Orange Day initiative, allowing GSK employees to take a paid day off to volunteer for a chosen community project, nonprofit organization or cause which they support.

Our people

Engineers as leaders: The art of the possible over the probable

GSK's David Lynch reflects on his career, the role of engineering in healthcare, and the path to leadership in the profession.

Patients & consumers

Living with COPD Every Day: Sean’s Story

Our people

Making healthy cool in school through Get HYPE Philly!

Patients & consumers

Whooping cough: confronting the hidden risk to infants

Whooping cough can be especially serious for infants—sometimes even fatal.

Our people

From the GSK archives: William Allen, scientist, businessman, abolitionist

When a company is as old as GSK (300 years this year!), the archives swell with items and documents related to our corporate heritage.

Patients & consumers

Inspiring Students through STEM Education Programs

In the next five years, the US will add eight million jobs in STEM fields. Yet more than 20% of all students, and half of all minority students, drop out of school before graduation.

Innovation

Scientists or detectives? Seeking new clues in COPD

We continuously strive for new opportunities to evolve our understanding of COPD that will help us meet individual patient needs.

How we do business

Helping to Change the World

Our people

The global as personal: GSK and The National Museum of African American History and Culture

Innovation

Can an iPhone transform the way we monitor and improve patient health?

Since 2014, we’ve been transforming the way we do research using digital technologies and channels to improve the efficiency of our research, and to improve patient care.

Patients & consumers

Take a Breather: 8 Fast Facts on Severe Asthma

You may know about asthma, and that 26 million people in the US have it. But, how much do you know about severe asthma?

Our people

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Our people

Persevering to accelerate your career success: lessons from an engineer

I was born and raised in Mexico and grew up loving both science and people. This love drove me to study Chemical Engineering which eventually helped me become an engineer, a line manager, and, currently, the director of the Future Leaders Program in Global Manufacturing and Supply at GSK.

How we do business

Letting the sunshine in – transparency that’ll grow trust

Patients & consumers

The power of advocacy: coming together for the patient

Access to healthcare

Global mission, local impact

We often hear of humanitarian work in other parts of the world, but here in the United States there is real need as well. Around 47 million in the US live in poverty.

Our people

From academia to industry: a new challenge

Professor Christopher Cooper joined GSK as a Global Medical Expert, Scientific Faculty, GSK Global Respiratory Franchise. Here he explains why he chose to move from academia to industry.

Our people

Andy Dundon: the design behind the device

Andy Dundon leads our Research and Development (R&D) Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices, including through the use of digital technologies.

Innovation

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections, where invasive surgery like organ transplants can’t be performed because it’s too risky, and where hospital wards are breeding grounds for disease.

Our people

Clinical Trials: Q&A with Murray Stewart

Patients & consumers

Beyond Breathing: When Is Asthma Really Under Control?

Patients & consumers

GSK Uncovers The State of Uncontrolled Asthma in America

Survey findings show more than two-thirds (67%) of adults with uncontrolled asthma in the US are living with the misperception that their condition is under control.

Our people

Respiratory disease: why we want to make a difference

Today too many people suffer unnecessarily because of the poor management of their asthma and COPD.

Access to healthcare

In Africa, markets matter for a healthy society

When it comes to improving access to healthcare in Africa, markets matter. From pharmaceutical companies to small clinics, an interconnected private market complements public sector services to help patients receive the healthcare they need, when and where they need it.

Our people

Safety first: Employee wellbeing rides on it

Every day, Rajendra rides his motorcycle 30 kilometres to and from the area he covers, and also uses it to travel to meet healthcare professionals.

Our people

Beyond manufacturing in Chile and Madagascar

Our people

Why I fight malaria: Laura's story

Our people

Making the global goals our business

Not everyone gets to live their dream job, but I feel extremely lucky and grateful that I do. I lead GSK’s global employee volunteering efforts, including PULSE, our flagship program.

Patients & consumers

8 simple activities that may not be so simple when you have severe asthma

Saying “I have asthma” may not be as simple as you think. There are different types of asthma, including mild, moderate or severe asthma and each can make every day activities difficult in their own way.

Innovation

Take a deep breath - your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity

Our people

Gary the "Resourceful Recycler”

GSK is targeting a carbon neutral value chain by 2050 and has ambitious goals to reduce carbon, water and waste in the meantime.

Our people

Tracy the "Courageous Problem-Solver”

Our people

George the "Science Liaison Leader”

Our people

Linda the "Neighborhood Health Advocate”

Linda, GSK Community Partnership Representative, 26-year employee of GSK, the second in a three-generation family of GSK’ers, and a Philadelphia native.

Our people

Putting responsible business principles into practice: spotlight on four GSK US "intrapreneurs"

Our responsible business reforms are taking hold here in the US market and with our US employees.

Innovation

GSK’s Chief Immunology Officer discusses unlocking the secrets of the immune system to tackle disease

As science evolves we are learning that the immune system does so much more than protect us from an outside attack.

Patients & consumers

Launching the Fostering Wellness initiative – young people, lead the way!

Jack Bailey, President GSK US Pharmaceuticals, and North Carolina Governor Pat McCrory and others announced the winners of our $1 million GSK IMPACT Grant.

Our people

Charting a path to success: my International Women's Day advice is for everyone

Innovation

Harnessing the electrical language of the body to treat disease

Our people

Rare Disease Day 2016: What it means to us

Rare Disease Day on 29th February holds personal significance for two colleagues working in our Rare Disease Unit; Jessica Imrie and Julie Venners Christensen both have children with rare disorders.

Our people

On the job with GSK's medical device research team

A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.

Our people

Volunteering in Kenya: a once in a lifetime experience

PULSE volunteer, Mizanul Islam shares his experience of working with Save the Children in Bungoma County, Kenya for six months in 2015.

Our people

Treating malaria: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

Our people

Simon Wright, Head of Child Survival at Save the Children gives a partnership perspective

Patients & consumers

The Power of 24hrs

Access to healthcare

TEDMED 2015: An interview with curator, Christine McNab

How does art tell the story of vaccines in a different way than other communications media?

Access to healthcare

TEDMED 2015: Art, inspired by vaccination

There are surprising similarities between an artist beginning a new work and a researcher on a quest to develop a vaccine.

Access to healthcare

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries.

Our people

War and peace: Ivo, Nobel prize winner

In the world of business—and scientific research—war metaphors abound. “Hitting our targets.” “Fighting cancer.” What we don’t see are many comparisons to peacekeeping.

Our people

Changing Lives

Innovation

Rare diseases: Q&A with Martin Andrews

How we do business

The hope for a cure for HIV/AIDS in our lifetime

In the past three decades, we’ve made advances in treatments for HIV/AIDS but a cure has remained elusive.

Patients & consumers

Every breath you take: Alison’s story

Imagine if every breath you took was a struggle; imagine waking up in the night short of breath and wheezing.

Innovation

Cell and gene therapy: a new era of medicine

Since the structure of DNA was discovered by James Watson and Francis Crick in 1953, significant advances have been made in our understanding of diseases caused by faulty genes.

Innovation

The race to richer data in clinical trials

That’s why we’re working with a range of partners, including the McLaren Technology Group and Medidata, to find new ways to use biosensors and mobile health platforms to improve patient care.

How we do business

Switching on to consumer choice: medicines for everyday health

Access to healthcare

Our humanitarian response to the Ebola outbreak

Access to healthcare

Malaria: life cycle of a parasite

Find out more about malaria and the life cycle of the parasites that cause it.

How we do business

Changing the way we work with healthcare professionals

Putting patients’ interests at the heart of every decision.

How we do business

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Access to healthcare

The fight against malaria

By the time the second hand on your watch has circled its dial, a child will have died of malaria.

Patients & consumers

Clinical trials: a patient's view

Innovation

Epigenetics: turn-ons and turn-offs

Patients & consumers

Science of a different stripe

How do the stripes in toothpaste get into the tubes and how is it that they come out of it so uniformly?

Innovation

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

Innovation

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Patients & consumers

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

Innovation

Bacteria: friends or foes?

Innovation

Data transparency

Innovation

Inside the open lab

"The biggest surprise for me was the openness,” says Thulasi Warrier. “I thought I would be put in a cubicle and not encouraged to speak.”

How we do business

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Access to healthcare

Collaborating to improve patient care

Over the past few years, we’ve seen a significant shift with organizations and individuals across the US healthcare system coming together to deliver, and reward, better value in healthcare.

Patients & consumers

Struggling for breath

Claudette, 54, stops on the short walk between the bus stop and her nearby apartment. She needs to catch her breath. She is a grandmother of two, and suffers from COPD.

How we do business

Biosecurity and pandemic preparedness

Back to top